Vima Therapeutics
Clinical trials sponsored by Vima Therapeutics, explained in plain language.
-
New drug combo aims to ease dystonia symptoms
Symptom relief Recruiting nowThis phase 2 trial tests whether VIM0423, a combination of two drugs, can reduce symptoms of isolated dystonia (a movement disorder causing muscle spasms). About 100 adults aged 18-65 with dystonia in at least two body areas will receive either VIM0423 or a placebo. Researchers w…
Phase: PHASE2 • Sponsor: Vima Therapeutics • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Dystonia study seeks to map Disease's Real-World toll
Knowledge-focused Recruiting nowThis study watches 200 people with isolated dystonia (affecting more than one body part) to see how the condition changes over time. Researchers will collect information on symptoms, daily activities, pain, and social life using standard rating scales. No experimental treatment i…
Sponsor: Vima Therapeutics • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC